Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin B Begg

Showing results (11-20 of 184) with videos related to

Pageof 19
Sort By:
Journal of the National Cancer Institute|August 22, 2002
On the use of familial aggregation in population-based case probands for calculating penetranceColin B Begg
The Oncologist|June 18, 2002
The mammography controversyColin B Begg
Clinical Trials (London, England)|July 13, 2016
EditorialColin B Begg
Biometrics|September 11, 2007
Letter to the editor of BiometricsColin B Begg
Clinical Trials (London, England)|December 2, 2016
EditorialColin B Begg
International Journal of Cancer|October 16, 2010
A strategy for distinguishing optimal cancer subtypesColin B Begg
Clinical Trials (London, England)|September 13, 2019
EditorialColin B Begg
Journal of Clinical Epidemiology|August 9, 2005
Systematic reviews of diagnostic accuracy studies require study by study examination: first for heterogeneity, and then for sources of heterogeneityColin B Begg
Clinical Trials (London, England)|February 20, 2020
The costs of cancer drugsColin B Begg
Clinical Trials (London, England)|March 11, 2015
Ethical concerns about adaptive randomizationColin B Begg
Pageof 19

Showing results (11-20 of 184) with videos related to

Sort By:
Pageof 19
Journal of the National Cancer Institute|August 22, 2002
On the use of familial aggregation in population-based case probands for calculating penetranceColin B Begg
The Oncologist|June 18, 2002
The mammography controversyColin B Begg
Clinical Trials (London, England)|July 13, 2016
EditorialColin B Begg
Biometrics|September 11, 2007
Letter to the editor of BiometricsColin B Begg
Clinical Trials (London, England)|December 2, 2016
EditorialColin B Begg
International Journal of Cancer|October 16, 2010
A strategy for distinguishing optimal cancer subtypesColin B Begg
Clinical Trials (London, England)|September 13, 2019
EditorialColin B Begg
Journal of Clinical Epidemiology|August 9, 2005
Systematic reviews of diagnostic accuracy studies require study by study examination: first for heterogeneity, and then for sources of heterogeneityColin B Begg
Clinical Trials (London, England)|February 20, 2020
The costs of cancer drugsColin B Begg
Clinical Trials (London, England)|March 11, 2015
Ethical concerns about adaptive randomizationColin B Begg
Pageof 19